Your browser doesn't support javascript.
loading
European Medicines Agency review of ixazomib (Ninlaro) for the treatment of adult patients with multiple myeloma who have received at least one prior therapy.
Tzogani, Kyriaki; Florez, Beatriz; Markey, Greg; Caleno, Mariapaola; Olimpieri, Odoardo Maria; Melchiorri, Daniela; Hovgaard, Doris Johanna; Sarac, Sinan Bardakci; Penttilä, Karri; Lapveteläinen, Tuomo; Salmonson, Tomas; Bergh, Jonas; Gisselbrecht, Christian; Pignatti, Francesco.
Afiliação
  • Tzogani K; European Medicines Agency, Amsterdam, The Netherlands.
  • Florez B; MHRA, London, UK.
  • Markey G; MHRA, London, UK.
  • Caleno M; AIFA, Roma, Italy.
  • Olimpieri OM; AIFA, Roma, Italy.
  • Melchiorri D; Dip. Physiology and Pharmacology, V. Erspamer, University of Rome La Sapienza, Roma, Italy.
  • Hovgaard DJ; Laegemiddelstyrelsen, Kobenhavn, Denmark.
  • Sarac SB; Laegemiddelstyrelsen, Kobenhavn, Denmark.
  • Penttilä K; Finnish Medicines Agency Fimea, Helsinki, Finland.
  • Lapveteläinen T; Finnish Medicines Agency Fimea, Helsinki, Finland.
  • Salmonson T; Lakemedelsverket, Uppsala, Sweden.
  • Bergh J; Radiumhemmet Microbiology and Tumorbiology Center, Karolinska University Hospital, Stockholm, Sweden.
  • Gisselbrecht C; Institut d'Hématologie, Hôpital Saint Louis Paris Diderot Université, Hospital Saint-Louis, Paris, France.
  • Pignatti F; European Medicines Agency, Amsterdam, The Netherlands.
ESMO Open ; 4(5): e000570, 2019.
Article em En | MEDLINE | ID: mdl-31555488
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2019 Tipo de documento: Article